annual CAPEX:
$2.28B-$1.04B(-31.37%)Summary
- As of today (September 17, 2025), TAK annual capital expenditures is $2.28 billion, with the most recent change of -$1.04 billion (-31.37%) on March 1, 2025.
- During the last 3 years, TAK annual CAPEX has risen by +$626.13 million (+37.82%).
- TAK annual CAPEX is now -51.21% below its all-time high of $4.68 billion, reached on March 31, 2023.
Performance
TAK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$519.53M-$73.99M(-12.47%)Summary
- As of today (September 17, 2025), TAK quarterly capital expenditures is $519.53 million, with the most recent change of -$73.99 million (-12.47%) on June 1, 2025.
- Over the past year, TAK quarterly CAPEX has dropped by -$364.76 million (-41.25%).
- TAK quarterly CAPEX is now -84.37% below its all-time high of $3.32 billion, reached on March 31, 2023.
Performance
TAK quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.91B-$364.76M(-16.03%)Summary
- As of today (September 17, 2025), TAK TTM capital expenditures is $1.91 billion, with the most recent change of -$364.76 million (-16.03%) on June 1, 2025.
- Over the past year, TAK TTM CAPEX has dropped by -$335.80 million (-14.95%).
- TAK TTM CAPEX is now -69.13% below its all-time high of $6.19 billion, reached on December 31, 2023.
Performance
TAK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TAK CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -31.4% | -41.3% | -14.9% |
3 y3 years | +37.8% | -31.4% | -6.0% |
5 y5 years | +13.9% | +38.0% | -3.3% |
TAK CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -51.2% | +37.8% | -84.4% | +88.0% | -69.1% | +4.8% |
5 y | 5-year | -51.2% | +37.8% | -84.4% | +88.0% | -69.1% | +15.0% |
alltime | all time | -51.2% | +902.1% | -84.4% | +486.0% | -69.1% | +2055.2% |
TAK CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $519.53M(-12.5%) | $1.91B(-16.0%) |
Mar 2025 | $2.28B(-31.4%) | $593.53M(+46.7%) | $2.28B(+6.5%) |
Dec 2024 | - | $404.50M(+2.9%) | $2.14B(-3.1%) |
Sep 2024 | - | $393.10M(-55.5%) | $2.21B(-1.8%) |
Jun 2024 | - | $884.29M(+94.4%) | $2.25B(-32.3%) |
Mar 2024 | $3.32B(-28.9%) | $454.77M(-4.0%) | $3.32B(-46.4%) |
Dec 2023 | - | $473.60M(+9.2%) | $6.19B(+2.2%) |
Sep 2023 | - | $433.78M(-77.8%) | $6.05B(+2.7%) |
Jun 2023 | - | $1.96B(-41.1%) | $5.90B(+25.5%) |
Mar 2023 | $4.68B(+182.5%) | $3.32B(+881.9%) | $4.70B(+157.5%) |
Dec 2022 | - | $338.58M(+22.5%) | $1.82B(-4.7%) |
Sep 2022 | - | $276.35M(-63.5%) | $1.91B(-5.8%) |
Jun 2022 | - | $757.69M(+67.8%) | $2.03B(+22.3%) |
Mar 2022 | $1.66B(-25.7%) | $451.49M(+5.3%) | $1.66B(-27.4%) |
Dec 2021 | - | $428.88M(+8.7%) | $2.29B(+0.5%) |
Sep 2021 | - | $394.38M(+2.0%) | $2.27B(+0.6%) |
Jun 2021 | - | $386.59M(-64.1%) | $2.26B(+0.5%) |
Mar 2021 | $2.23B(+11.3%) | $1.08B(+158.6%) | $2.25B(+29.7%) |
Dec 2020 | - | $416.57M(+9.6%) | $1.74B(-14.9%) |
Sep 2020 | - | $380.04M(+1.0%) | $2.04B(+3.2%) |
Jun 2020 | - | $376.44M(-33.1%) | $1.98B(-0.7%) |
Mar 2020 | $2.00B(+65.6%) | $562.41M(-22.0%) | $1.99B(+8.3%) |
Dec 2019 | - | $721.36M(+127.9%) | $1.84B(+32.6%) |
Sep 2019 | - | $316.50M(-19.1%) | $1.39B(+8.6%) |
Jun 2019 | - | $391.01M(-4.6%) | $1.28B(+5.6%) |
Mar 2019 | $1.21B(+4.5%) | $409.99M(+52.1%) | $1.21B(+17.6%) |
Dec 2018 | - | $269.61M(+30.3%) | $1.03B(+10.4%) |
Sep 2018 | - | $206.89M(-36.0%) | $931.67M(-23.9%) |
Jun 2018 | - | $323.04M(+41.2%) | $1.22B(+6.5%) |
Mar 2018 | $1.16B(+11.9%) | $228.71M(+32.2%) | $1.15B(-7.6%) |
Dec 2017 | - | $173.04M(-65.4%) | $1.24B(-12.1%) |
Sep 2017 | - | $499.68M(+101.0%) | $1.42B(+24.4%) |
Jun 2017 | - | $248.57M(-23.0%) | $1.14B(+11.2%) |
Mar 2017 | $1.03B(+46.4%) | $322.84M(-6.2%) | $1.02B(+12.5%) |
Dec 2016 | - | $344.26M(+54.9%) | $909.07M(+22.5%) |
Sep 2016 | - | $222.22M(+66.3%) | $742.35M(+4.1%) |
Jun 2016 | - | $133.61M(-36.1%) | $713.04M(+0.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | $706.65M(-28.6%) | $208.98M(+17.7%) | $707.92M(+5.8%) |
Dec 2015 | - | $177.53M(-8.0%) | $669.02M(-7.9%) |
Sep 2015 | - | $192.91M(+50.1%) | $726.30M(+0.8%) |
Jun 2015 | - | $128.50M(-24.5%) | $720.56M(-26.8%) |
Mar 2015 | $989.64M(+26.3%) | $170.09M(-27.6%) | $983.91M(+20.9%) |
Dec 2014 | - | $234.80M(+25.4%) | $813.83M(+40.6%) |
Sep 2014 | - | $187.18M(-52.2%) | $579.02M(+47.8%) |
Jun 2014 | - | $391.84M(+140.9%) | $391.84M(-73.2%) |
Mar 2014 | $783.85M(-42.1%) | - | - |
Mar 2013 | $1.35B(+72.7%) | - | - |
Mar 2012 | $783.98M(-45.9%) | - | - |
Mar 2011 | $1.45B(+54.8%) | $162.67M(-50.9%) | $1.46B(-11.9%) |
Dec 2010 | - | $331.09M(-24.7%) | $1.66B(+1.8%) |
Sep 2010 | - | $439.82M(-16.9%) | $1.63B(+17.9%) |
Jun 2010 | - | $529.54M(+46.6%) | $1.38B(+46.7%) |
Mar 2010 | $936.40M(+138.7%) | $361.14M(+19.7%) | $943.18M(+62.0%) |
Dec 2009 | - | $301.75M(+57.5%) | $582.04M(+107.7%) |
Sep 2009 | - | $191.64M(+116.2%) | $280.29M(+216.2%) |
Jun 2009 | - | $88.65M | $88.65M |
Mar 2009 | $392.37M(+37.5%) | - | - |
Mar 2008 | $285.40M(+14.5%) | - | - |
Mar 2007 | $249.34M(-12.1%) | - | - |
Mar 2006 | $283.53M(-43.2%) | - | - |
Mar 2005 | $499.30M(+4.2%) | - | - |
Mar 2004 | $479.29M(+74.5%) | - | - |
Mar 2003 | $274.63M(-8.5%) | - | - |
Mar 2002 | $300.28M(+23.3%) | - | - |
Mar 2001 | $243.63M(-23.4%) | - | - |
Mar 2000 | $318.09M(+39.7%) | - | - |
Mar 1999 | $227.69M(-17.7%) | - | - |
Mar 1998 | $276.53M(-1.7%) | - | - |
Mar 1997 | $281.26M(+6.1%) | - | - |
Mar 1996 | $265.05M(-42.5%) | - | - |
Mar 1995 | $460.97M(+28.1%) | - | - |
Mar 1994 | $359.84M(+7.1%) | - | - |
Mar 1993 | $336.03M(+14.9%) | - | - |
Mar 1992 | $292.57M(-11.7%) | - | - |
Mar 1991 | $331.18M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual capital expenditures?
- What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
What is Takeda Pharmaceutical Company Limited annual capital expenditures?
The current annual CAPEX of TAK is $2.28B
What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual capital expenditures is $4.68B
What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
Over the past year, TAK annual capital expenditures has changed by -$1.04B (-31.37%)
What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
The current quarterly CAPEX of TAK is $519.53M
What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly capital expenditures is $3.32B
What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
Over the past year, TAK quarterly capital expenditures has changed by -$364.76M (-41.25%)
What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
The current TTM CAPEX of TAK is $1.91B
What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM capital expenditures is $6.19B
What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
Over the past year, TAK TTM capital expenditures has changed by -$335.80M (-14.95%)